Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -70.947% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1cc(C(N)=O)c2cc(Br)ccc2n1
[b] COc1cccc(CN2CC(C(=O)N3CCN(c4ccc(Cl)cc4)CC3)CCC2=O)c1
Answer: b. COc1cccc(CN2CC(C(=O)N3CCN(c4ccc(Cl)cc4)CC3)CCC2=O)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(CN2CC(C(=O)N3CCN(c4ccc(Cl)cc4)CC3)CCC2=O)c1
COc1cccc(CN2CC(C(=O)N3CCN(c4ccc(Cl)cc4)CC3)CCC2=O)c1
5-[4-(4-chlorophenyl)piperazine-1-carbonyl]-1-[(3-methoxyphenyl)methyl]piperidin-2-one